ATE366810T1 - HUMAN P51 GENES AND THEIR GENE PRODUCTS - Google Patents

HUMAN P51 GENES AND THEIR GENE PRODUCTS

Info

Publication number
ATE366810T1
ATE366810T1 AT99910698T AT99910698T ATE366810T1 AT E366810 T1 ATE366810 T1 AT E366810T1 AT 99910698 T AT99910698 T AT 99910698T AT 99910698 T AT99910698 T AT 99910698T AT E366810 T1 ATE366810 T1 AT E366810T1
Authority
AT
Austria
Prior art keywords
genes
human
gene products
protein
recombinant
Prior art date
Application number
AT99910698T
Other languages
German (de)
Inventor
Yoji Ikawa
Shuntaro Ikawa
Masuo Obinata
Original Assignee
Otsuka Pharma Co Ltd
Yoji Ikawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Yoji Ikawa filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE366810T1 publication Critical patent/ATE366810T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A recombinant p51 protein comprising an amino acid sequence of SEQ ID NO: 1, wherein said recombinant p51 protein is expressed from a transformant with the p51 expression vector, an isolated antibody or fragment thereof binding specifically to said p51 protein and a kit comprising said antibody or fragment thereof.
AT99910698T 1998-03-27 1999-03-24 HUMAN P51 GENES AND THEIR GENE PRODUCTS ATE366810T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10046798 1998-03-27

Publications (1)

Publication Number Publication Date
ATE366810T1 true ATE366810T1 (en) 2007-08-15

Family

ID=14274724

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99910698T ATE366810T1 (en) 1998-03-27 1999-03-24 HUMAN P51 GENES AND THEIR GENE PRODUCTS
AT07013470T ATE512162T1 (en) 1998-03-27 1999-03-24 ANTIBODIES AGAINST THE P51 PROTEIN

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT07013470T ATE512162T1 (en) 1998-03-27 1999-03-24 ANTIBODIES AGAINST THE P51 PROTEIN

Country Status (12)

Country Link
US (4) US7132276B1 (en)
EP (2) EP1065270B1 (en)
JP (1) JP4336926B2 (en)
CN (1) CN100340665C (en)
AT (2) ATE366810T1 (en)
CA (1) CA2324649C (en)
CY (1) CY1111763T1 (en)
DE (1) DE69936513D1 (en)
DK (1) DK1847607T3 (en)
ES (1) ES2366234T3 (en)
PT (1) PT1847607E (en)
WO (1) WO1999050412A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000818A1 (en) * 1999-06-29 2001-01-04 Nippon Kayaku Kabushiki Kaisha Gene encoding promoter domain of tumor suppressor gene p51 and use thereof
EP1728210A2 (en) * 2004-02-27 2006-12-06 Aureon Laboratories, Inc. Methods and systems for predicting occurrence of an event
CN102181571A (en) * 2011-05-20 2011-09-14 清华大学 Special primers for assisting in identifying genes related to swine genetic stability and application thereof
CN102181570A (en) * 2011-05-20 2011-09-14 清华大学 Special primer for performing auxiliary identification on mouse genetic stability related gene and application thereof
CN104212879B (en) * 2013-06-05 2016-09-21 上海派森诺生物科技股份有限公司 A kind of method based on magnesphere high flux exploitation genome SSR marker

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744455B1 (en) 1996-02-02 1998-04-24 Sanofi Sa NOVEL NUCLEIC ACID SEQUENCES OF THE FAMILY OF TUMOR SUPPRESSOR FACTORS, CORRESPONDING EXPRESSION PRODUCTS AND THEIR APPLICATIONS
US6451979B1 (en) 1997-05-12 2002-09-17 Dana-Farber Cancer Institute, Inc. Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies
WO1999019357A2 (en) * 1997-10-15 1999-04-22 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
US7294459B1 (en) * 1997-10-15 2007-11-13 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
AU3094999A (en) 1998-03-18 1999-10-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
AU3208699A (en) 1998-03-27 1999-10-18 Johns Hopkins University, The P40 protein acts as an oncogene
DE19822985C1 (en) 1998-05-25 2000-01-13 Fraunhofer Ges Forschung P53 family tumor suppressor genes

Also Published As

Publication number Publication date
JP4336926B2 (en) 2009-09-30
US7132276B1 (en) 2006-11-07
ES2366234T3 (en) 2011-10-18
EP1065270A1 (en) 2001-01-03
EP1847607A1 (en) 2007-10-24
US7754857B2 (en) 2010-07-13
US7964367B2 (en) 2011-06-21
EP1847607B1 (en) 2011-06-08
CY1111763T1 (en) 2015-10-07
DE69936513D1 (en) 2007-08-23
ATE512162T1 (en) 2011-06-15
DK1847607T3 (en) 2011-07-18
WO1999050412A1 (en) 1999-10-07
US20100285499A1 (en) 2010-11-11
PT1847607E (en) 2011-08-25
US20090142783A1 (en) 2009-06-04
CA2324649C (en) 2007-05-15
EP1065270A4 (en) 2004-12-29
EP1065270B1 (en) 2007-07-11
CA2324649A1 (en) 1999-10-07
HK1034288A1 (en) 2001-10-19
US7553933B2 (en) 2009-06-30
CN1295615A (en) 2001-05-16
US20060115852A1 (en) 2006-06-01
CN100340665C (en) 2007-10-03

Similar Documents

Publication Publication Date Title
DE69634726D1 (en) HUMAN CTLA-8 AND USE OF CTLA-8 SIMILAR PROTEINS
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
ATE335078T1 (en) OVEREXPRESSION OF MAMMAL AND VIRUS PROTEINS
ATE382055T1 (en) WNT-1 RELATED POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THEREOF
BR9507594A (en) Process for the treatment of glomerulonephritis in a patient in need of this treatment article of manufacture hybridoma antibody 5g.1; 1 isolated nucleic acid protein isolated polypeptide vector recombinant host cell nucleic acid vector process to produce an isolated isolated anti-c5 antibody c5 polypeptide process to produce an isolated anti-c5 antibody protein isolated nucleic acid molecule process to produce an anti-c5 antibody anti-c5 antibody 5g46k fragment 5g27k peptide 5g325aa isolated peptide 5g200aa isolated oligopeptide isolated process to induce an animal to produce an anti- c5 process for identifying an anti-c5 antibody and process for treating a patient in need of complete inhibition
ATE339878T1 (en) MYC-BINDING ZINC FINGER PROTEINS, THEIR PRODUCTION AND THEIR USE
GB9722320D0 (en) Human cell cycle checkpoint proteins
ATE534742T1 (en) POLYPEPTIDES AND NUCLEIC ACIDS OF PHORPHORYMONAS GINGIVALIS
CY1111763T1 (en) ANTIBODIES AGAINST THE PROTEIN p51
WO2000040723A3 (en) Methods and products for delivering nucleic acids
DE69832299D1 (en) UNIQUE POLYPEPTIDES INCLUDE TROPONIN I AND TROPONIN C
NO980122D0 (en) Enamel matrix-related polypeptide
NO874704L (en) MINACTIVIN MANUFACTURED BY RECOMBINANT DNA TECHNOLOGY.
DE59108261D1 (en) HIV-gag protein peptides, their production and use
EP0723014A3 (en) cDNA of DOCK180 gene and DOCK180 protein
EP0723016A3 (en) Activating factor of leukocytes
WO2002012475A3 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
WO2003018806A1 (en) Novel human bmcc1 gene
ATE335005T1 (en) HUMAN PROTEIN WITH IN VITRO ANTIPROLIFERATIVE ACTIVITY.
WO2003099995A3 (en) Murine ortholog of the human disrupted-in-schizophrenia 1 gene
CO5070672A1 (en) HUMAN PROTEIN C POLYPEPTIDE
AU7871101A (en) Nucleic acids and proteins showing increased expression dose under salt stress
WO2003008621A3 (en) 87144, human amino acid transporter family member and uses therefor
WO2000063370A3 (en) Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
WO2001046412A3 (en) Interaction proteins for the stat transcription factor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties